Efavirenz and neuropsychiatric effects.
作者信息
Dheda Mukesh
机构信息
Pharmacovigilance Centre for Public Health Programmes, National Department of Health, South Africa.
School of Health Science, University of KwaZulu-Natal, South Africa.
出版信息
South Afr J HIV Med. 2017 Apr 24;18(1):741. doi: 10.4102/sajhivmed.v18i1.741. eCollection 2017.
Abstract
摘要
相似文献
1
Efavirenz and neuropsychiatric effects.依非韦伦与神经精神效应。
South Afr J HIV Med. 2017 Apr 24;18(1):741. doi: 10.4102/sajhivmed.v18i1.741. eCollection 2017.
2
Neuropsychiatric manifestations among HIV-1 infected African patients receiving efavirenz-based cART with or without tuberculosis treatment containing rifampicin.接受含依非韦伦的抗逆转录病毒治疗（cART）且接受或未接受含利福平的抗结核治疗的HIV-1感染非洲患者的神经精神表现。
Eur J Clin Pharmacol. 2018 Nov;74(11):1405-1415. doi: 10.1007/s00228-018-2499-0. Epub 2018 Jul 12.
3
A comparison of neuropsychiatric adverse events during 12 weeks of treatment with etravirine and efavirenz in a treatment-naive, HIV-1-infected population.在未经治疗的 HIV-1 感染人群中，比较依曲韦林和依非韦伦治疗 12 周时的神经精神不良事件。
AIDS. 2011 Jan 28;25(3):335-40. doi: 10.1097/QAD.0b013e3283416873.
4
Effect of Valerian in Preventing Neuropsychiatric Adverse Effects of Efavirenz in HIV-Positive Patients: A Pilot Randomized, Placebo-Controlled Clinical Trial.缬草对预防HIV阳性患者依非韦伦的神经精神不良反应的作用：一项前瞻性随机、安慰剂对照临床试验。
Ann Pharmacother. 2017 Jun;51(6):457-464. doi: 10.1177/1060028017696105. Epub 2017 Feb 1.
5
Improvement of Depression and Anxiety After Discontinuation of Long- Term Efavirenz Treatment.长期依非韦伦治疗停药后抑郁和焦虑症状的改善
CNS Neurol Disord Drug Targets. 2015;14(6):811-8. doi: 10.2174/1871527314666150325235847.
6
Neuropsychiatric complications of antiretroviral therapy.抗逆转录病毒疗法的神经精神并发症
Drug Saf. 2006;29(10):865-74. doi: 10.2165/00002018-200629100-00004.
7
Effect of concomitant use of montelukast and efavirenz on neuropsychiatric adverse events.孟鲁司特与依法韦仑联合使用对神经精神不良事件的影响。
Ann Pharmacother. 2014 Jan;48(1):145-8. doi: 10.1177/1060028013510396. Epub 2013 Nov 5.
8
Neuropsychiatric symptoms in Tanzanian HIV-infected children receiving long-term efavirenz treatment: a multicentre, cross-sectional, observational study.坦桑尼亚接受长期依非韦伦治疗的 HIV 感染儿童的神经精神症状：一项多中心、横断面、观察性研究。
Lancet HIV. 2019 Apr;6(4):e250-e258. doi: 10.1016/S2352-3018(18)30329-1. Epub 2019 Feb 12.
9
Prediction of neuropsychiatric adverse events associated with long-term efavirenz therapy, using plasma drug level monitoring.使用血浆药物水平监测预测与长期依非韦伦治疗相关的神经精神不良事件。
Clin Infect Dis. 2005 Dec 1;41(11):1648-53. doi: 10.1086/497835. Epub 2005 Oct 19.
10
Incidence and predictors of adverse drug events in an African cohort of HIV-infected adults treated with efavirenz.在接受依非韦伦治疗的非洲成人HIV感染队列中药物不良事件的发生率及预测因素
Germs. 2015 Sep 1;5(3):83-91. doi: 10.11599/germs.2015.1075. eCollection 2015 Sep.
引用本文的文献
1
Ascorbic Acid Prevents Efavirenz-Induced Anxiety-Like Behavior and Brain Oxidative Stress in Zebrafish.抗坏血酸可预防依非韦伦诱导的斑马鱼焦虑样行为和脑氧化应激。
Oxid Med Cell Longev. 2025 Jun 1;2025:8867221. doi: 10.1155/omcl/8867221. eCollection 2025.
2
Aging of adult lifetime survivors with perinatal HIV.围产期感染艾滋病毒的成年长期存活者的衰老情况
Curr Opin HIV AIDS. 2025 Jul 1;20(4):379-387. doi: 10.1097/COH.0000000000000938. Epub 2025 May 21.
3
Electroencephalography as a diagnostic tool for late-onset efavirenz neurotoxicity syndrome.脑电图作为诊断迟发性依非韦伦神经毒性综合征的一种工具。
PLoS One. 2023 Nov 10;18(11):e0288055. doi: 10.1371/journal.pone.0288055. eCollection 2023.
4
Severe efavirenz associated neurotoxicity: A retrospective cohort study.严重的依非韦伦相关神经毒性：一项回顾性队列研究。
S Afr J Infect Dis. 2023 Jul 24;38(1):522. doi: 10.4102/sajid.v38i1.522. eCollection 2023.
5
Efavirenz: History, Development and Future.依非韦伦：历史、研发与未来。
Biomolecules. 2022 Dec 31;13(1):88. doi: 10.3390/biom13010088.
本文引用的文献
1
Efavirenz as a cause of ataxia in children.依非韦伦是儿童共济失调的一个病因。
S Afr Med J. 2015 Nov;105(11):897-8. doi: 10.7196/SAMJ.2015.v105i11.9451.
2
Association between efavirenz as initial therapy for HIV-1 infection and increased risk for suicidal ideation or attempted or completed suicide: an analysis of trial data.依法韦仑作为HIV-1感染初始治疗与自杀意念、自杀未遂或自杀死亡风险增加之间的关联：试验数据分析
Ann Intern Med. 2014 Jul 1;161(1):1-10. doi: 10.7326/M14-0293.
3
Severe efavirenz-induced vacuolar axonopathy complicated by fatal aspiration pneumonia.严重的依非韦伦诱导的空泡性轴索病并发致命性吸入性肺炎。
Br J Clin Pharmacol. 2012 Dec;74(6):1070-2. doi: 10.1111/j.1365-2125.2012.04299.x.
4
High prevalence of the CYP2B6 516G-->T(*6) variant and effect on the population pharmacokinetics of efavirenz in HIV/AIDS outpatients in Zimbabwe.CYP2B6 516G→T（*6）变体在津巴布韦艾滋病毒/艾滋病门诊患者中的高流行率及其对依非韦伦群体药代动力学的影响。
Eur J Clin Pharmacol. 2008 Apr;64(4):357-65. doi: 10.1007/s00228-007-0412-3. Epub 2007 Dec 5.
5
Impact of CYP2B6 polymorphism on hepatic efavirenz metabolism in vitro.CYP2B6基因多态性对体外依法韦仑肝脏代谢的影响。
Pharmacogenomics. 2007 Jun;8(6):547-58. doi: 10.2217/14622416.8.6.547.
6
Efavirenz-induced catatonia.依非韦伦所致紧张症
AIDS. 2002 Sep 6;16(13):1841-2. doi: 10.1097/00002030-200209060-00024.
7
Central nervous system adverse effects with efavirenz: case report and review.
Pharmacotherapy. 2002 Jul;22(7):930-3. doi: 10.1592/phco.22.11.930.33624.
Zotero 插件